Current Report Filing (8-k)
November 23 2015 - 2:11PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date
of earliest event reported) November 19, 2015
MEDIFIRST
SOLUTIONS, INC.
(Exact
name of registrant as specified in its charter)
Nevada |
|
333-178825 |
|
27-3888260 |
State or other jurisdiction |
|
Commission File Number |
|
IRS Employer |
incorporation |
|
|
|
Identification No. |
4400 Route 9 South, Suite 1000, Freehold, NJ |
|
07728 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrant's telephone number, including area code: (732)-786-8044
(Former name or former address, if changed since last
report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant
to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Section 5- | Corporate Governance
and Management |
Item 5.03 |
Amendment to Articles of Incorporation or Bylaws; Change of Fiscal Year |
Effective
November 19, 2015, the Company amended its Articles of Incorporation to increase its authorized capital to 1,500,000,000
shares of Common Stock and 1,000,000 shares of Preferred Stock. All other provisions of the Articles of Incorporation in
effect prior to this amendment remained unchanged.
Signatures
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this amended report to be signed on
its behalf by the undersigned hereunto duly authorized.
|
MEDIFIRST
SOLUTIONS, INC. |
|
|
|
Dated:
November 23, 2015 |
By: |
/s/
Bruce Schoengood |
|
|
President
and Chief Executive Officer |
Exhibit 16.1 |
Letter
from David A. Aronson, CPA, P.A., pursuant to Item 304 of Regulation S-K |
4
Exhibit 16.1
David A. Aronson, CPA,
P.A.
1000 NE 176th Street
North Miami Beach, FL 33162
June 25, 2015
United States Securities & Exchange Commission
100 F Street, NE
Washington, D.C.20549
Ladies & Gentlemen:
We have read the disclosures on the Form 8K report of Medifirst
Solutions, Inc. dated June 25, 2015 and we are in agreement with the statements contained therein, as they pertain to our engagement
and subsequent dismissal.
Very truly yours,
/s/ David A. Aronson,
CPA, P.A.